EBRO 2017

Danish study: Overall Survival, n=3376, left vs right, no IMN vs IMN RT, Lise B J Thorsen et al, JClinOncol 2016,

100

72.2% 67.8% Adjusted HR: 0.84 (0.73; 0.97) P=0.015 Difference: 4.4%

log-rank p = 0.03

100

Events All

IMN RT 359 No IMN RT 437 1586 Log-rank p=0.03 Adjusted HR: 0.84 (0.73-0.97) Events All IMN RT 1485 359 No IMN RT 437 1586 Log-rank p=0.03 Adjusted HR: 0.84 (0.73-0.97) 1485 0 1 2 3 4 5 6 7 8 9

25 0 75

25 50 75

0

0

Time after treatment (years) 0 1 2 3 4 5 6 7 8 9

1586 1507 1352 1170 542 No IMN RT 1485 1406 1299 1136 556 IMN RT At risk 1586 1507 1352 1170 542 No IMN RT 1485 1406 1299 1136 556 IMN RT At risk Time after treatment (years)